Amara Sayed

NPI: 1831215763
Total Payments
$542.72
2023 Payments
$82.95
Companies
7
Transactions
12
Medicare Patients
19,967
Medicare Billing
$1.7M

Payment Breakdown by Category

Food & Beverage$426.59 (78.6%)
Education$116.13 (21.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $426.59 8 78.6%
Education $116.13 4 21.4%

Top Paying Companies

Company Total Records Latest Year
Galderma Laboratories, L.P. $167.42 4 $0 (2022)
PFIZER INC. $121.36 1 $0 (2017)
Lilly USA, LLC $99.03 2 $0 (2018)
Janssen Biotech, Inc. $82.95 1 $0 (2023)
EPI Health, LLC $32.38 1 $0 (2022)
Incyte Corporation $25.02 2 $0 (2022)
DERMIRA, INC. $14.56 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2023 $82.95 1 Janssen Biotech, Inc. ($82.95)
2022 $81.24 4 EPI Health, LLC ($32.38)
2020 $27.15 2 DERMIRA, INC. ($14.56)
2019 $130.99 2 Galderma Laboratories, L.P. ($130.99)
2018 $99.03 2 Lilly USA, LLC ($99.03)
2017 $121.36 1 PFIZER INC. ($121.36)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/28/2023 Janssen Biotech, Inc. TREMFYA (Drug) Education In-kind items and services $82.95 General
Category: Immunology
10/12/2022 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $23.84 General
09/01/2022 EPI Health, LLC CLODERM (Drug), MINOLIRA EXTENDED RELEASE, WYNZORA Food and Beverage In-kind items and services $32.38 General
Category: DERMATOLOGY
04/05/2022 Incyte Corporation OPZELURA (Drug) Education Cash or cash equivalent $12.51 General
Category: Dermatology
04/05/2022 Incyte Corporation OPZELURA (Drug) Education Cash or cash equivalent $12.51 General
Category: Dermatology
10/15/2020 DERMIRA, INC. QBREXZA (Drug) Food and Beverage In-kind items and services $14.56 General
Category: DERMATOLOGY
02/04/2020 Galderma Laboratories, L.P. AKLIEF (Drug) Food and Beverage In-kind items and services $12.59 General
Category: ACNE
02/26/2019 Galderma Laboratories, L.P. EPIDUO FORTE (Drug) Education In-kind items and services $8.16 General
Category: ACNE
02/08/2019 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $122.83 General
02/21/2018 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $12.46 General
Category: Immunology
02/07/2018 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $86.57 General
Category: Immunology
11/02/2017 PFIZER INC. EUCRISA (Drug) Food and Beverage In-kind items and services $121.36 General
Category: DERMATOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 18 4,925 10,430 $1.3M $422,794
2022 23 5,291 11,066 $1.4M $448,440
2021 20 5,002 10,376 $1.3M $420,656
2020 25 4,749 9,451 $1.1M $360,641
Total Patients
19,967
Total Services
41,323
Medicare Billing
$1.7M
Procedure Codes
86

All Medicare Procedures & Services

86 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
11102 Biopsy of related skin growth, first growth Office 2023 888 1,242 $274,333 $90,459 33.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 871 1,285 $240,044 $78,051 32.5%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 376 541 $188,311 $67,103 35.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 339 470 $124,503 $42,275 34.0%
11103 Biopsy of related skin growth, each additional growth Office 2023 481 1,010 $112,655 $39,037 34.7%
17000 Destruction of precancer skin growth, 1 growth Office 2023 762 1,048 $144,938 $37,471 25.9%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 625 4,202 $58,324 $21,101 36.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 194 194 $44,407 $14,374 32.4%
17110 Destruction of skin growth, 1-14 growths Office 2023 74 108 $26,032 $9,003 34.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 61 61 $20,792 $6,671 32.1%
69100 Biopsy of ear Office 2023 74 82 $17,333 $3,888 22.4%
11104 Punch biopsy, first skin growth Office 2023 35 35 $9,647 $3,218 33.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 85 88 $10,187 $3,185 31.3%
12031 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less Office 2023 11 13 $7,259 $2,641 36.4%
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm Office 2023 15 16 $5,990 $2,001 33.4%
10060 Simple or single drainage of skin abscess Office 2023 12 12 $3,094 $1,162 37.6%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 11 11 $1,711 $605.52 35.4%
11105 Punch biopsy, each additional skin growth Office 2023 11 12 $1,543 $547.81 35.5%
11102 Biopsy of related skin growth, first growth Office 2022 899 1,277 $282,012 $94,007 33.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 893 1,275 $238,247 $75,834 31.8%
17004 Destruction of precancer skin growth, 15 or more growths Office 2022 379 532 $185,179 $65,562 35.4%
11103 Biopsy of related skin growth, each additional growth Office 2022 496 1,043 $116,336 $41,344 35.5%
17000 Destruction of precancer skin growth, 1 growth Office 2022 806 1,138 $157,385 $41,087 26.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 347 451 $119,470 $38,666 32.4%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 641 4,441 $61,641 $22,733 36.9%

About Amara Sayed

Amara Sayed is a Dermatology healthcare provider based in Georgetown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831215763.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amara Sayed has received a total of $542.72 in payments from pharmaceutical and medical device companies, with $82.95 received in 2023. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($426.59).

As a Medicare-enrolled provider, Sayed has provided services to 19,967 Medicare beneficiaries, totaling 41,323 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Location Georgetown, TX
  • Active Since 03/22/2007
  • Last Updated 06/14/2013
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1831215763

Products in Payments

  • EUCRISA (Drug) $121.36
  • TALTZ (Drug) $99.03
  • TREMFYA (Drug) $82.95
  • CLODERM (Drug) $32.38
  • OPZELURA (Drug) $25.02
  • QBREXZA (Drug) $14.56
  • AKLIEF (Drug) $12.59
  • EPIDUO FORTE (Drug) $8.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Georgetown